Clinical Study
C-Reactive Protein Levels in the Brugada Syndrome
Table 2
Demographic and clinical characteristics of the Brugada patients with CRP < or ≥ 2 mg/l.
| | CRP < 2 mg/L () | CRP ≥ 2 mg/L () | value |
95%CI | | Univariate analysis | Multivariate analysis |
| | Age (years) | | | ns | — | | | Male | 24 (86%) | 25 (96%) | ns | — | | | Coved-type ECG | 13 (46%) | 20 (77%) | .022 | ns | | | VT/FV | 1 (4%) | 4 (15%) | ns | — | | | Family history | 5 (18%) | 10 (38%) | ns | — | | | Syncope | 5 (18%) | 12 (46%) | .025 | ns | | | Aborted SCA | 0 | 3 (12%) | ns | | | | Overall symptoms (syncope and/or aborted SCA) | 5 (18%) | 15 (58%) | .018 | 0.039 | 1.07–18.79 | | ICD† | 8 (29%) | 18 (69%) | .003 | ns | |
|
|
CRP: C-reactive protein; VT: ventricular tachycardia; FV: ventricular fibrillation; SCD: sudden cardiac death; ICD: implantable cardioverter-defibrillator; †placement of ICD was done before (>3 months) or after blood testing for serum CRP concentration.
|
